Back to Treatments

Treatment

Standard 6-Month Regimen (Isoniazid, Rifampicin, Pyrazinamide, Ethambutol then Isoniazid, Rifampicin for active TB)

1
Conditions
500
Trials
200K
Participants
58%
Average Safety

Condition Evidence

Drug-susceptible tuberculosis

500 trials · 200K participants

95% effectiveness · 58% safety
Standard 6-Month Regimen (Isoniazid, Rifampicin, Pyrazinamide, Ethambutol then Isoniazid, Rifampicin for active TB) | DFDA